Venture Capital Deals

Exosome Diagnostics, a New York-based developer of fluid-based molecular diagnostics, has raised $27 million in Series B funding. QIAGEN and Arcus Ventures co-led the round, and were joined by Tiger Partners, CD Ventures, Monashee Capital and return backers NGN Capital and Forbion Capital Partners. www.exosomedx.com

Persimmon Technologies Corp., a Wakefield, Mass.–based provider of vacuum robotics and hybrid-field motor technologies for the chip, LED and solar equipment markets, has raised $14 million in Series B funding. ABB Group led the round, and was joined by Berwind Private Equity. ABB and Berwind joined Intel Capital, Nidec Sankyo and The Bernard Gordon Charitable Remainder Trust.www.persimmontech.com

Complete Solar Solution, a Foster City, Calif.-based provider of end-to-end solar energy installation services, has raised $5 million in new VC funding led by the Ecosystem Integrity Fund.www.completesolar.com

DataRPM, a Fairfax, Va.-based provider of cognitive business intelligence, has raised $5.1 million in Series A funding. InterWest Partners led the round, and was joined by CIT GAP Funds.www.datarpm.com

CityAds Media, a Moscow-based affiliate marketing platform, has raised $5 million in VC funding fromKlever Internet Investments. www.cityads.ru

Spritz, a Stoneham, Mass.-based developer of speed-reading technology, “is in the process of closing” a $3.54 million seed round led by Digicel, according to TechCrunch. www.spritzinc.com

Surfingbird.ru, a Russian collaborative content discovery service, has raised $2.5 million in VC funding from Klever Internet Investments. www.surfingbird.ru

Ulmon, a Vienna-based mobile travel guide company, has raised an undisclosed amount of VC funding from Global Founders Capital.  www.ulmon.com

Private Equity Deals

Arsenal Capital Partners has acquired Kel-Tech Inc., a Midland, Texas-based provider of specialty chemicals and related services to production, field stimulation and drilling operations in the oil and gas market. Sellers included Hastings Equity Partners. No financial terms were disclosed.

The Blackstone Group has agreed to acquire more than an 80% stake in Accuvant Inc., a Denver-based cybersecurity company, for approximately $150 million, according to the WSJ. Existing Accuvant backer Sverica International will retain a minority stake. www.accuvant.com

CareCore National, a Bluffton, S.C.-based healthcare specialty benefits management company, has raised an undisclosed amount of private equity funding from General Atlantic.www.carecorenational.com

Gemini Investors has sponsored a recap of Ultracor Inc., a Livermore, Calif.-based maker of composite materials and systems for the space and aerospace industries. No financial terms were disclosed. Existing Ultracore backer Salt Creek Capital will retain an ownership position.www.ultracorinc.com

Incline Equity Partners has sponsored a recapitalization of Hartland Controls, a Rock Falls, Ill.-based provider of electrical system components to the HVAC market. No financial terms were disclosed. www.hartland-controls.com

Lanier Parking Solutions, an Atlanta-based parking and transportation management company, has raised an undisclosed amount of equity funding from Antarctica Capital. www.lanierparking.com

SCT Holdings, a Sanford, Fla.–based provider of software that improved vehicle fuel efficiency and performance, has acquired Bully Dog, an American Falls, Idaho–based provider of automotive calibration solutions to the truck aftermarket. No financial terms were disclosed. SCT is a portfolio company of the Global Environment Fund. www.sctflash.com

Sentinel Capital Partners has completed its previously-announced acquisition of Checkers Drive-In Restaurants, a Tampa, Fla.-based chain of more than 800 hamburger restaurants, from Wellspring Capital Partners. No financial terms were disclosed. www.checkers.com

Standard Chartered Private Equity has acquired a 25.8% stake in Copperbelt Energy Corp., a listed Zambian provider of power solutions to African copper producers, for $57 million.www.cecinvestor.com

IPOs

Arysta LifeScience, a Japanese agricultural chemicals company owned by Permira, is considering an IPO on the NYSE that could value the company at around $4 billion, according to the FT.www.arystalifescience.com

Borderfree Inc., a New York-based provider of ecommerce solutions for retailers, has set its IPO terms to 5 million shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $457 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol BRDR, with Credit Suisse and RBC Capital Markets serving as lead underwriters. It reports a $654,000 net loss on around $110 million of 2013 revenue, compared to $192,000 in net income on $81 million in revenue for 2012. Shareholders include Pitango Venture Capital (32.81% pre-IPO stake), Adams Street Partners (21.69%), Delta Ventures (12.38%), Venture Strategy Partners (5.85%), Canaan Partners and Viola Credit. www.borderfree.com

Castlight Health, an online application that lets companies provide employees with personalized shopping tools for healthcare benefits, has increased its IPO price range from $9-$11 per share to $13-$15 per share. It still plans to offer 11.1 million shares, and list on the NYSE under ticker symbol CSLT. Goldman Sachs and Morgan Stanley are serving as lead underwriters. Castlight reports a $62 million net loss on $13 million in revenue for 2013, compared to a $35 million net loss on $4 million in revenue for 2012. Shareholders include Venrock (20.6% pre-IPO stake), Oak Investment Partners (15.8%), Maverick Capital (10.2%), Fidelity Investments (9.8%) and The Wellcome Trust (8.7%).www.castlight.com

Cerulean Pharma Inc., a Cambridge, Mass.-based developer of nanoparticle-based drugs, has filed for a $75 million IPO. It plans to trade on the Nasdaq under ticker symbol CERU, with Leerink Partners serving as lead underwriter. Shareholders include Polaris Partners (32.3% pre-IPO stake), Venrock (20.8%), Lily Ventures (16.2%), Crown Ventures (10.9%) and Lux Capital (9.4%). www.ceruleanrx.com

Lombard Medical, a British maker of endovascular stent-grafts for repairing aortic aneurysms, has filed for an $80 million IPO. It plans to trade on the Nasdaq under ticker symbol EVAR, with Jefferies and Barclays serving as lead underwriters. The company’s shares currently trade on London’s AIM under ticker LMT, but the AIM listing will cease once this offering is completed. Shareholders include Invesco Asset Management (39% pre-IPO stake), Abingworth (17.8%), Fidelity Investment International (9.5%) and LSP Life Sciences (5.7%). www.lombardmedical.com

Paycom Software Inc., an Oklahoma City-based provider of human capital management SaaS solutions, has filed for a $100 million IPO. It plans to trade on the NYSE under ticker symbol PAYC, with Barclays and J.P. Morgan serving as lead underwriters. The company reports $7.7 million in net income on around $108 million in revenue for 2013, compared to $4.2 million of net income on $77 million in revenue for 2012. Welsh, Carson, Anderson & Stowe holds a 56.6% pre-IPO ownership stake. www.paycomonline.com

RadiumOne, a San Francisco-based online advertising company, is in the “final stages” of preparations for a Q3 IPO, according to Bloomberg. The company expects to generate more than $100 million in 2014 revenue, and has raised more than $30 million in VC funding from firms like Adams Street Partners, Trinity Ventures, Crosslink Capital and DFJ Esprit. www.radiumone.com

Phibro Animal Health, a Teaneck, N.J.-based animal health and mineral nutrition company, has filed for a $230 million IPO. It plans to trade on the Nasdaq under ticker symbol PAHC, with BofA Merrill Lynch, Morgan Stanley and Barclays serving as lead underwriter. The company reports $25 million in net income on $653 million in revenue for the fiscal year ending June 30, 2013. Shareholders include 3i Group. www.pahc.com

TriVascular Technologies Inc., a Santa Rosa, Calif.-based developer of minimally-invasive technologies to treat abdominal aortic aneurysms, has filed for a $100 million IPO. It plans to trade on the Nasdaq under ticker symbol TRIV, with J.P. Morgan and Credit Suisse serving as lead underwriters. The company reports a $50 million net loss on $19.5 million in revenue for 2013, compared to a $43 million net loss on $5 million in revenue for 2012. Shareholders include New Enterprise Associates (26.5% pre-IPO stake), Delphi Ventures (21.3%), MPM Capital (14.1%) and Kearny Venture Partners (6%). www.trivascular.com

Versartis Inc., a Mountain View, Calif.-based developer of therapeutics for patients with endocrine disorders, has set its IPO terms to 4.6 million shares being offered at between $16 and $19 per share. It would have an initial market cap of approximately $382 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol VSAR, with Morgan Stanley and Citigroup serving as lead underwriters. Shareholders in the pre-revenue company include New Leaf Venture Partners (24.4% pre-IPO stake), Index Ventures (22.4%), Advent Venture Partners (16.3%), Aisling Capital (11.9%) and Sofinnova Ventures (6.8%). www.versatis.com

Virtu Financial Inc., a New York-based high-speed trading company partially owned by Silver Lake, has filed for a $100 million IPO. It plans to trade on the Nasdaq under ticker symbol VIRT, with Goldman Sachs, J.P. Morgan and Sandler O’Neill serving as lead underwriters. The company reports $182 million in net income on $665 million in revenue for 2013, compared to an $88 million net income on $616 million in revenue for 2012. www.virtu.com

Zoe’s Kitchen Inc., a Plano, Texas-based fast casual restaurant concept, has filed for an $80.5 million IPO. It plans to trade on the NYSE under ticker symbol ZOES, with Jefferies, Piper Jaffray and Baird serving as lead underwriters. The company reports a $3.7 million net loss on $116 million in revenue for 2013, compared to a $253k net loss on $78 million in revenue for 2012. Shareholders includeBrentwood Associates. www.zoeskitchen.com

M&A

Chobani Inc., a New Berlin, N.Y.-based maker of Greek yogurt, has hired Bank of America to find a buyer for around 20% of the company, according to Reuters. The process would value Chobani at around $2.5 billion, and comes after Chobani opted against an IPO. www.chobani.com

Kabam, a free-to-play gaming company that has raised around $125 million in VC funding, has acquired Phoenix Age, a San Francisco-based mobile gaming studio whose titles include Castle Age and Underworld Empire. No financial terms were disclosed. Kabam backers include Canaan Partners, Betfair, Google Ventures, Intel Capital, Redpoint Ventures, Pinnacle Ventures, Performance Equity Management and SK Telecom Ventures. www.kabam.com

Minerals Technologies (NYSE: MTX) has agreed to acquire Illinois-based specialty materials company AMCOL International Corp. (NYSE: ACO) for approximately $1.7 billion, or $45.75 per share. It beat out a rival offer from France’s Imerys (Paris: NK). www.amcol.com

Priceline (Nasdaq: PCLN) has acquired Qlika, an Israeli ad targeting startup, for $3 million, according to Re/Code. Qlika had raised nearly $2 million in seed funding from UpWest Labs, Hillsven Capital and individual angels. www.qlika.com

Warburg Pincus is seeking a buyer for iParadigms, an Oakland-based provider of educational software for plagiarism prevention and content verification, according to Reuters. The deal reportedly could be valued at upwards of $750 million, or 15x EBITDA. www.iparadigms.com

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com